Skolkovo resident startup ExoAtlet , which makes rehabilitation exoskeletons that help disabled people to walk again, has raised $5 million in investment to expand its business to Europe and beyond. The funding is being provided by the Korean company Cosmo...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Skolkovo resident ExoAtlet , the inventor of rehabilitation exoskeletons that help disabled people to walk again, has set its sights for expansion on Japan, where it is setting up a joint venture with its South Korean partners and investors. Dennis Ahn...
The Golden Autumn agricultural trade fair is to a large extent a celebration of Russian traditions. Individual regions of Russia present their local produce on their own stand, often accompanied by people dressed in folk costumes who sing, dance or play traditional...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
The first building of the Moscow International Medical Cluster (MMMK), a planned state-of-the-art medical facility being built at the Skolkovo innovation centre, is growing visibly on a daily basis. Moscow Mayor Sergei Sobyanin visited the site , where construction...
A Russian company is hoping to revolutionise the treatment of HIV patients around the world with the help of a grant from the Skolkovo Foundation. Currently, Russia's one million HIV patients take a daily cocktail of tablets. Viriom is working on...
The Skolkovo Foundation has signed an agreement with the Turku Science Park in Finland to create a 200 million euro ‘Biocity’ – a leading biomedical research facility. Victor Vekselberg, right, and Rikumatti Levomaki signing the deal...